Trump Reaffirms US Commitment to India Underscoring Potential for Enhanced Economic Ties Heard on the Streets Annual StockPicking Contest Returns for Eighth Edition Endurance Technologies IPO Opens Key Details and Market Implications Prediction Market Investments Persist Despite Regulatory Uncertainty UK Student Loan Inquiry Reveals Widespread Financial Distress Among Graduates Coeur Mining CDE Q1 2026 Earnings EPS Misses Street Estimates as Costs Pressure Bottom Line ALOY Q1 2024 Earnings WiderthanExpected Loss Raises Concerns Despite Stock Uptick BK Q1 2026 Earnings EPS Surpasses Estimates by 1326 Beasley Broadcast Group Inc BBGI Q4 2025 Earnings Deep Loss Reported Amid Challenging Advertising Environment EP Q3 2025 Earnings Loss Per Share Reported Amid Ongoing Industry Headwinds Ategrity Specialty Insurance ASIC Edges Higher Approaching Resistance Cognition Therapeutics Inc CGTX Slips Modestly as Stock Hovers Near Support Zone iOThree Limited IOTR Surges 65 as Shares Test Key Resistance Near 225 Solid Biosciences SLDB Surges 393 as Bullish Momentum Builds AUTL Flatlines at 168 Autolus Therapeutics Consolidates Near Key Support Theriva Biologics TOVX Faces Pressure Stock Slides 8 as Key Support Levels Are Tested SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms MDV Q1 2026 Earnings Massive EPS Miss Sends Stock Lower April Jobs Report Preview What to Expect as Labor Market Cools BNL Q1 2026 Earnings Strong EPS Surprise of 53 Exceeds Analyst Expectations Palo Alto Networks PANW Q1 2026 Earnings Strong EPS Beat Drives Stock Higher SCKT Q1 2026 Earnings Net Loss of 011 per Share as Revenue Details Remain Unavailable HDSN Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Declines BBDC Q1 2026 Earnings EPS Misses Estimates Amidst Stable Asset Performance United Homes Group Q4 2025 Earnings Modest Profitability Achieved Amid Quiet Market Reception DGICA Q1 2026 Earnings EPS Falls Short of Estimates ERII Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Market Today Key Indices Navigate Mixed Signals Amid Economic Data Invesco Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Dermata Therapeutics DRMA Shares Climb 385 as Stock Tests Key Resistance Levels